Skip to content

Compliance of dairy products versus oral nutrition supplements in patients with a risk for malnutrition.

Compliance of dairy products versus oral nutrition supplements in patients with a risk for malnutrition. - Dairy.Com

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41996
Enrollment
131
Registered
2015-07-30
Start date
2015-11-02
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ondervoeding malnutrition

Interventions

Participants receive a high-protein diet: the experimental group receives extra (protein-rich) dairy products, and the control group receives extra oral nutrition supplements for in between use in o
Malnutrition
Protein

Sponsors

FrieslandCampina Nederland BV
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: * Risk for malnutrition (MUST = 0 or 1 point and PG-SGA SF score >= 4 and

Exclusion criteria

Exclusion criteria: * Use of oral nutrition supplements in the past six months at time of inclusion. * Receiving treatment of a dietician at time of inclusion. * High current daily protein intake (less than 12 gram difference between current intake and protein requirement). * Protein requirements >18 gram protein per day. * Prescription of oral nutrition supplements by the dietician. * Contra-indication for dairy products (e.g. lactose-intolerance, cow milk allergy). * Protein restriction ( 2 months ago); Duchenne muscular dystrophy; Gout. * Fluid restriction (6 months). * Eating disorder. * Dementia. * Distance from home to the UMCG is greater than 70 km. (due to practical reasons concerning distribution of the products).

Design outcomes

Primary

MeasureTime frame
The main study parameter is compliance, specified as adherence to prescription of daily protein goals (daily protein intake). A compliance questionnaire will be assessed to list the experiences of the participant about associated factors of compliance.

Secondary

MeasureTime frame
Secondary study parameters are (1) patient experiences (2) urine nitrogen secretion, (13) nutritional status, (24) body composition (BMI, bio-electrical impedance analysis), and (35) hand grip strength.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)